Skip to main content
Log in

Single time-point AF screening does not appear to be cost effective in older patients in Germany

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Notes

  1. NT-proB-type Natriuretic Peptide

Reference

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Single time-point AF screening does not appear to be cost effective in older patients in Germany. PharmacoEcon Outcomes News 886, 24 (2021). https://doi.org/10.1007/s40274-021-08002-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-021-08002-4

Navigation